SOURCE: SpectraScience, Inc.

February 13, 2012 09:00 ET

SpectraScience to Present at the LHA Life Sciences & Medtech Virtual Conference on February 16

SAN DIEGO, CA--(Marketwire - Feb 13, 2012) - SpectraScience, Inc. (OTCQB: SCIE) (PINKSHEETS: SCIE), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will present to investors as part of the LHA Life Sciences & Medical Technologies Virtual Conference on Thursday, February 16, 2012, at Noon Eastern time.

A webcast of the presentation will be accessible online at the PrecisionIR event site: http://www.investorcalendar.com/IC/CEPage.asp?ID=167332. An archived version will be available for 30 days.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.

Contact Information

  • Contact:
    SpectraScience, Inc.
    Jim Dorst
    Chief Financial Officer
    (858) 405-9933

    Investor Relations
    LHA
    Don Markley
    Email Contact
    (310) 691-7100